Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors
Clinical trial NCT02740933 · UNKNOWN
Trial details
- NCT number
- NCT02740933
- Sponsor
- Massachusetts General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.